Skip to content

Clinical trials

Completed Cognitive Dysfunction trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Completed Country / region: United Kingdom Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20092
20104
20121
20133
20144
20154
20161
20177
20185
20194
20204
20215
20227
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Actinogen Medical2
Anglia Ruskin University2
Bournemouth University2
Imperial College London2
King's College London2
Middlesex University2
Northumbria University2
Novoic Limited2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction56
Dementia15
Alzheimer Disease11
Stroke4
Mental Disorders3
Nervous System Diseases3
Schizophrenia3
Brain Diseases2
Central Nervous System Diseases2
Dementia, Vascular2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.